296 related articles for article (PubMed ID: 15115988)
1. The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
Wan S; Yim AP; Johnson JL; Shukla N; Angelini GD; Smith FC; Dashwood MR; Jeremy JY
J Thorac Cardiovasc Surg; 2004 May; 127(5):1317-22. PubMed ID: 15115988
[TBL] [Abstract][Full Text] [Related]
2. Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
Wan S; Shukla N; Yim AP; Johnson JL; Angelini GD; Jeremy JY
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):494-500. PubMed ID: 17258588
[TBL] [Abstract][Full Text] [Related]
3. Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts.
Wan S; Arifi AA; Chan MC; Yip JH; Ng CS; Chow LT; Yim AP; Jeremy JY
Eur J Cardiothorac Surg; 2006 May; 29(5):742-6; discussion 747. PubMed ID: 16581260
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
Wan S; Shukla N; Angelini GD; Yim AP; Johnson JL; Jeremy JY
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1033-9. PubMed ID: 17903525
[TBL] [Abstract][Full Text] [Related]
5. A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening.
Jeremy JY; Bulbulia R; Johnson JL; Gadsdon P; Vijayan V; Shukla N; Smith FC; Angelini GD
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1766-72. PubMed ID: 15173735
[TBL] [Abstract][Full Text] [Related]
6. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
[TBL] [Abstract][Full Text] [Related]
7. Role of osteopontin in the development of neointimal hyperplasia in vein grafts.
Kang N; Ng CS; Hu J; Qiu ZB; Underwood MJ; Jeremy JY; Wan S
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1384-9. PubMed ID: 22219474
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts.
Murphy GJ; Johnson TW; Chamberlain MH; Rizvi SI; Wyatt M; George SJ; Angelini GD; Karsch KR; Oberhoff M; Newby AC
Cardiovasc Res; 2007 Feb; 73(3):607-17. PubMed ID: 17187765
[TBL] [Abstract][Full Text] [Related]
9. Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts.
Dashwood MR; Mehta D; Izzat MB; Timm M; Bryan AJ; Angelini GD; Jeremy JY
Atherosclerosis; 1998 Apr; 137(2):233-42. PubMed ID: 9622266
[TBL] [Abstract][Full Text] [Related]
10. Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts.
Rajathurai T; Rizvi SI; Lin H; Angelini GD; Newby AC; Murphy GJ
Circ Cardiovasc Interv; 2010 Apr; 3(2):157-65. PubMed ID: 20332383
[TBL] [Abstract][Full Text] [Related]
11. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
12. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
[TBL] [Abstract][Full Text] [Related]
13. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
[TBL] [Abstract][Full Text] [Related]
14. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of intimal proliferation after vein grafting by chitosan nanoparticle with proliferation cell nuclear antigen-antisense oligo deoxy nucleotides].
Chen Z; Zhang H; Xia J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Dec; 21(12):1348-54. PubMed ID: 18277682
[TBL] [Abstract][Full Text] [Related]
16. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
17. Time-course of medial and intimal thickening in pig venous arterial grafts: relationship to endothelial injury and cholesterol accumulation.
Angelini GD; Bryan AJ; Williams HM; Soyombo AA; Williams A; Tovey J; Newby AC
J Thorac Cardiovasc Surg; 1992 Jun; 103(6):1093-103. PubMed ID: 1597973
[TBL] [Abstract][Full Text] [Related]
18. All-trans-retinoic acid decreases cell proliferation and increases apoptosis in an animal model of vein bypass grafting.
Leville CD; Osipov VO; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
Surgery; 2000 Aug; 128(2):178-84. PubMed ID: 10922989
[TBL] [Abstract][Full Text] [Related]
19. Bypass graft disease: analysis of proliferative activity in human aorto-coronary bypass grafts.
Hilker M; Buerke M; Lehr HA; Oelert H; Hake U
Heart Surg Forum; 2002; 5 Suppl 4():S331-41. PubMed ID: 12759206
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 and vein graft occlusion in patients undergoing bypass surgery.
Dashwood MR
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():78-87. PubMed ID: 19335750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
